Curasight
BioStock: Curasight gets green light from EMA in phase II prostate cancer trial
Read the full article at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se
Datum | 2024-04-22, kl 08:45 |
Källa | Cision |
![](https://static.allaaktier.se/ads/etoro-logo.png)
Copy Trading innebär inte investeringsråd. Värdet på dina investeringar kan gå upp eller ned. Ditt kapital löper risk.